Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia

NCT01576588 is registered in ClinicalTrials.gov with Prof. Dr. Med. Laimonas Griskevicius as lead sponsor.

NCT NCT01576588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01576588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia
Lead sponsor
Prof. Dr. Med. Laimonas Griskevicius
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell chronic lymphocytic leukemia